PatientsVille.com Logo

Victoza Side Effects

PatientsVille

Common Victoza Side Effects


The most commonly reported Victoza side effects (click to view or check a box to report):

Nausea (2264)
Blood Glucose Increased (1054)
Diarrhoea (910)
Decreased Appetite (794)
Vomiting (747)
Weight Decreased (669)
Headache (544)
Pancreatitis (491)
Abdominal Pain Upper (384)
Constipation (364)
Blood Glucose Decreased (330)
Injection Site Haematoma (325)
Dizziness (295)
Pancreatitis Acute (261)
Eructation (261)
Abdominal Discomfort (259)
Malaise (247)
Injection Site Pain (238)
Fatigue (236)
Injection Site Erythema (231)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Victoza Side Effects Reported to FDA



Victoza Side Effect Report#9858524
Intraocular Pressure Increased
This is a report of a 62-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: type 2 diabetes mellitus, who was treated with Victoza (dosage: 1.8 Mg, Qd, start time:
Nov 26, 2012), combined with:
  • Metformin
  • Lantus
and developed a serious reaction and side effect(s): Intraocular Pressure Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in Intraocular Pressure Increased side effect.
Victoza Side Effect Report#9858469
Nausea, Weight Decreased, Headache, Pyrexia, Rash Pruritic, Rash, Heart Rate Increased
This report suggests a potential Victoza Nausea side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: diabetes mellitus management and used Victoza (dosage: Given Into/under The Skin) starting
Oct 10, 2013. After starting Victoza the patient began experiencing various side effects, including: Nausea, Weight Decreased, Headache, Pyrexia, Rash Pruritic, Rash, Heart Rate IncreasedAdditional drugs used concurrently: NA.The patient was hospitalized. Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Nausea, may still occur.
Victoza Side Effect Report#9858466
Urinary Retention, Cough, Respiratory Tract Congestion
This Urinary Retention problem was reported by a consumer or non-health professional from US. A 55-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: weight control,blood glucose increased. On NS this consumer started treatment with Victoza (dosage: NA). The following drugs were being taken at the same time: NA. When using Victoza, the patient experienced the following unwanted symptoms/side effects: Urinary Retention, Cough, Respiratory Tract CongestionAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Urinary Retention, may become evident only after a product is in use by the general population.
Victoza Side Effect Report#9855453
Pancreatic Carcinoma
This Pancreatic Carcinoma side effect was reported by a pharmacist from ES. A 55-year-old female patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus.The patient was prescribed Victoza (drug dosage: Unk), which was initiated on 201211. Concurrently used drugs: NA..After starting to take Victoza the consumer reported adverse symptoms, such as: Pancreatic CarcinomaThese side effects may potentially be related to Victoza.
Victoza Side Effect Report#9852304
Coronary Artery Occlusion, Vomiting
This is a report of a 62-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: type 2 diabetes mellitus, who was treated with Victoza (dosage: 0.6 Mg Qd, start time: 201310), combined with: NA. and developed a serious reaction and side effect(s): Coronary Artery Occlusion, Vomiting after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in Coronary Artery Occlusion side effect. The patient was hospitalized.
Victoza Side Effect Report#9849008
Pancreatic Carcinoma, Metastases To Liver
This report suggests a potential Victoza Pancreatic Carcinoma side effect(s) that can have serious consequences. A 62-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Victoza (dosage: NA) starting 201302. After starting Victoza the patient began experiencing various side effects, including: Pancreatic Carcinoma, Metastases To LiverAdditional drugs used concurrently: NA. Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pancreatic Carcinoma, may still occur.
Victoza Side Effect Report#9848932
Pancreatitis
This Pancreatitis problem was reported by a physician from US. A 55-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On
Oct 30, 2013 this consumer started treatment with Victoza (dosage: NA). The following drugs were being taken at the same time: NA. When using Victoza, the patient experienced the following unwanted symptoms/side effects: PancreatitisThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pancreatitis, may become evident only after a product is in use by the general population.
Victoza Side Effect Report#9848257
Pancreatic Carcinoma, Bile Duct Cancer
This Pancreatic Carcinoma side effect was reported by a physician from US. A 79-year-old male patient (weight:NA) experienced the following symptoms/conditions: diabetes mellitus.The patient was prescribed Victoza (drug dosage: NA), which was initiated on
Dec 12, 2012. Concurrently used drugs:
  • Bystolic
  • Lipitor
  • Glipizide
  • Imdur
  • Losartan
  • Asa
  • Ranitidine
  • Metformin
.After starting to take Victoza the consumer reported adverse symptoms, such as: Pancreatic Carcinoma, Bile Duct CancerThese side effects may potentially be related to Victoza. The patient was hospitalized.
Victoza Side Effect Report#9837969
Cerebrovascular Accident, Tachyarrhythmia
This is a report of a 60-year-old male patient (weight: NA) from FR, suffering from the following health symptoms/conditions: NA, who was treated with Victoza (dosage: 1.2 Mg, Qd, start time: NS), combined with:
  • Metformine
and developed a serious reaction and side effect(s): Cerebrovascular Accident, Tachyarrhythmia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in Cerebrovascular Accident side effect.
Victoza Side Effect Report#9837963
Pancreatitis
This report suggests a potential Victoza Pancreatitis side effect(s) that can have serious consequences. A 74-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus and used Victoza (dosage: 0.6 Mg, Qd) starting
Jan 09, 2014. After starting Victoza the patient began experiencing various side effects, including: PancreatitisAdditional drugs used concurrently: NA. Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pancreatitis, may still occur.
Victoza Side Effect Report#9837957
Pancreatic Carcinoma Metastatic
This Pancreatic Carcinoma Metastatic problem was reported by a consumer or non-health professional from US. A 71-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On 2003 this consumer started treatment with Victoza (dosage: 1.2 Mg, Qd). The following drugs were being taken at the same time:
  • Janumet
  • Baby Aspirin (Unk)
  • Baby Aspirin
  • Vitamin D /00107901/ (Unk)
  • Vitamin E (Unk)
  • Fish Oil Omega 3 (Unk)
When using Victoza, the patient experienced the following unwanted symptoms/side effects: Pancreatic Carcinoma MetastaticThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pancreatic Carcinoma Metastatic, may become evident only after a product is in use by the general population.
Victoza Side Effect Report#9832302
Acute Coronary Syndrome, Pancreatic Carcinoma Metastatic, Hyperglycaemia
This Acute Coronary Syndrome side effect was reported by a physician from CH. A 65-year-old male patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus.The patient was prescribed Victoza (drug dosage: 1.8 Mg, Qd), which was initiated on NS. Concurrently used drugs:
  • Tresiba (80 U, Qd)
  • Novorapid (Unk)
  • Valsartan (0.5 Tab, Qd (320mg/25mg))
  • Actos (30 Mg, Qd)
  • Pantozol /01263204/ (40 Mg, Bid)
  • Pantozol /01263204/
  • Thioctacid /00213801/ (600 Mg, Qd)
  • Humalog (Unk (according To Outline))
.After starting to take Victoza the consumer reported adverse symptoms, such as: Acute Coronary Syndrome, Pancreatic Carcinoma Metastatic, HyperglycaemiaThese side effects may potentially be related to Victoza. The patient was hospitalized.
Victoza Side Effect Report#9832084
Pancreatic Carcinoma Metastatic
This is a report of a 65-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: type 2 diabetes mellitus, who was treated with Victoza (dosage: 1.8 Mg, Qd, start time:
Aug 29, 2012), combined with:
  • Iron (27 Mg, Unk)
  • Vitamin B12 /00056201/ (1000 ?g, Qd)
  • Aspirin E.c (81 Mg, Qd)
  • Vitamin D3 (2000 Iu, Bid)
  • Fish Oil (120 Mg-180 Mg, Qd)
  • Glucosamine Chondroitin /01430901/ (600 Mg-750 Mg, Qd)
  • Nitrostat (0.4 Mg, Prn)
  • Amlodipine Besylate (2.5 Mg, Qd)
and developed a serious reaction and side effect(s): Pancreatic Carcinoma Metastatic after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in Pancreatic Carcinoma Metastatic side effect.
Victoza Side Effect Report#9832062
Stent Placement
This report suggests a potential Victoza Stent Placement side effect(s) that can have serious consequences. A 59-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus and used Victoza (dosage: 1.8 Mg Daily) starting 2008. After starting Victoza the patient began experiencing various side effects, including: Stent PlacementAdditional drugs used concurrently: NA. Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Stent Placement, may still occur.
Victoza Side Effect Report#9832061
Stent Placement
This Stent Placement problem was reported by a consumer or non-health professional from US. A 59-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On 2008 this consumer started treatment with Victoza (dosage: 1.8 Mg Daily). The following drugs were being taken at the same time: NA. When using Victoza, the patient experienced the following unwanted symptoms/side effects: Stent PlacementAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Stent Placement, may become evident only after a product is in use by the general population.
Victoza Side Effect Report#9830536
Cholangiocarcinoma, Metastases To Liver
This Cholangiocarcinoma side effect was reported by a health professional from GB. A 51-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Victoza (drug dosage: 1.2 Mg), which was initiated on 2007. Concurrently used drugs:
  • Sitagliptin (100 Mg)
  • Buscopan (Unk)
  • Chlorpromazine (75 Mg)
  • Humulin I (Unk)
  • Omeprazole (20 Mg)
  • Pregabalin (75 Mg)
.After starting to take Victoza the consumer reported adverse symptoms, such as: Cholangiocarcinoma, Metastases To LiverThese side effects may potentially be related to Victoza.
Victoza Side Effect Report#9830530
Diarrhoea, Malaise
This is a report of a 67-year-old male patient (weight: NA) from GB, suffering from the following health symptoms/conditions: NA, who was treated with Victoza (dosage: Unk, start time:
Dec 06, 2013), combined with:
  • Amitriptyline (Unk)
  • Aspirin (Unk)
  • Atorvastatin (Unk)
  • Ezetrol (Unk)
  • Gliclazide (Unk)
  • Lansoprazole (Unk)
  • Lercanidipine (Unk)
  • Metformin (Unk)
and developed a serious reaction and side effect(s): Diarrhoea, Malaise after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in Diarrhoea side effect.
Victoza Side Effect Report#9830519
Blood Triglycerides Increased, Pancreatitis Acute
This report suggests a potential Victoza Blood Triglycerides Increased side effect(s) that can have serious consequences. A 50-year-old female patient (weight: NA) from FR was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus,dyslipidaemia and used Victoza (dosage: 1.80 Mg, Qd) starting 2008. After starting Victoza the patient began experiencing various side effects, including: Blood Triglycerides Increased, Pancreatitis AcuteAdditional drugs used concurrently:
  • Omacor (3 Df, Qd)
  • Metformin (1700 Mg, Qd)
  • Lasilix /00032601/ (40 Mg, Qd)
  • Triatec /00116401/ (5 Mg, Qd)
  • Kaleorid (1000 Mg, Qd)
  • Kardegic (75 Mg, Qd)
  • Cardensiel (2.50 Mg, Qd)
  • Nureflex (1200 Mg, Qd)
The patient was hospitalized. Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Blood Triglycerides Increased, may still occur.
Victoza Side Effect Report#9820254
Pancreatic Carcinoma
This Pancreatic Carcinoma problem was reported by a consumer or non-health professional from US. A 63-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On 2011 this consumer started treatment with Victoza (dosage: 18mg/3ml Once Daily). The following drugs were being taken at the same time: NA. When using Victoza, the patient experienced the following unwanted symptoms/side effects: Pancreatic CarcinomaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pancreatic Carcinoma, may become evident only after a product is in use by the general population.
Victoza Side Effect Report#9818164
Cerebrovascular Accident
This Cerebrovascular Accident side effect was reported by a health professional from US. A 72-year-old female patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus.The patient was prescribed Victoza (drug dosage: 1.8 Mg, Qd), which was initiated on
Jul 11, 2013. Concurrently used drugs: NA..After starting to take Victoza the consumer reported adverse symptoms, such as: Cerebrovascular AccidentThese side effects may potentially be related to Victoza. The patient was hospitalized.
Victoza Side Effect Report#9818162
Pancreatic Carcinoma Metastatic, Off Label Use
This is a report of a 62-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: diabetes mellitus,obesity, who was treated with Victoza (dosage: 1.8 Mg, Qd, start time: 201203), combined with: NA. and developed a serious reaction and side effect(s): Pancreatic Carcinoma Metastatic, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in Pancreatic Carcinoma Metastatic side effect. The patient was hospitalized.
Victoza Side Effect Report#9813042
International Normalised Ratio Decreased, Off Label Use
This report suggests a potential Victoza Injection International Normalised Ratio Decreased side effect(s) that can have serious consequences. A 49-year-old male patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: diabetes mellitus,weight control and used Victoza Injection (dosage: 0.6 Mg, Qd) starting
Jul 07, 2011. After starting Victoza Injection the patient began experiencing various side effects, including: International Normalised Ratio Decreased, Off Label UseAdditional drugs used concurrently: NA. Although Victoza Injection demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as International Normalised Ratio Decreased, may still occur.
Victoza Side Effect Report#9808099
Hyperamylasaemia, Hyperlipasaemia, Abdominal Pain
This Hyperamylasaemia problem was reported by a health professional from FR. A 66-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On 2013 this consumer started treatment with Victoza (dosage: NA). The following drugs were being taken at the same time: NA. When using Victoza, the patient experienced the following unwanted symptoms/side effects: Hyperamylasaemia, Hyperlipasaemia, Abdominal PainAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Hyperamylasaemia, may become evident only after a product is in use by the general population.
Victoza Side Effect Report#9805502
Hyperamylasaemia, Hyperlipasaemia
This Hyperamylasaemia side effect was reported by a health professional from FR. A 57-year-old male patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus.The patient was prescribed Victoza (drug dosage: 1.8 Mg, Qd), which was initiated on
Mar 06, 2012. Concurrently used drugs:
  • Novonorm
  • Metformine (1000 Mg)
  • Inegy (10/20)
  • Allopurinol
  • Coversyl /00790702/
  • Temerit
  • Kardegic
.After starting to take Victoza the consumer reported adverse symptoms, such as: Hyperamylasaemia, HyperlipasaemiaThese side effects may potentially be related to Victoza.
Victoza Side Effect Report#9805496
Adenocarcinoma Pancreas
This is a report of a 72-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: type 2 diabetes mellitus, who was treated with Victoza (dosage: Unk, start time: 200701), combined with:
  • Byetta (Unk)
  • Januvia (Unk)
  • Janumet (Unk)
  • Bydureon (Unk)
and developed a serious reaction and side effect(s): Adenocarcinoma Pancreas after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in female patients, resulting in Adenocarcinoma Pancreas side effect. The patient was hospitalized.


  3 of 359 


The appearance of Victoza on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


What are common Victoza Side Effects for Women?

Women Side EffectsReports
Nausea 1586
Blood Glucose Increased 600
Diarrhoea 594
Vomiting 536
Decreased Appetite 496
Headache 405
Weight Decreased 403
Pancreatitis 261
Abdominal Pain Upper 249
Constipation 246

What are common Victoza Side Effects for Men?

Men Side EffectsReports
Nausea 671
Blood Glucose Increased 453
Diarrhoea 313
Decreased Appetite 297
Weight Decreased 264
Pancreatitis 222
Vomiting 208
Headache 139
Abdominal Pain Upper 134
Pancreatitis Acute 132

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Victoza reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Victoza Side Effects

    Did You Have a Victoza Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Victoza for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Victoza Safety Alerts, Active Ingredients, Usage Information

    NDC0169-4060
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameVictoza
    Nameliraglutide (rDNA origin) injection
    Dosage FormINJECTION, SOLUTION
    RouteSUBCUTANEOUS
    On market since20100125
    LabelerNovo Nordisk
    Active Ingredient(s)LIRAGLUTIDE
    Strength(s)6
    Unit(s)mg/mL
    Pharma ClassGLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (

    More About Victoza

    Side Effects reported to FDA: 8970

    Victoza safety alerts: 2011

    Reported deaths: 157

    Reported hospitalizations: 1313

    Latest Victoza clinical trials